Abdul Razak
drabdulrazak.bsky.social
Abdul Razak
@drabdulrazak.bsky.social
Neonatologist pursuing PhD at Monash University
Pinned
Thrilled to contribute to this groundbreaking work on cell therapy, where we successfully demonstrated that a targeted dose of stem cells can be obtained from extremely preterm infants and safely reinfused

www.thelancet.com/journals/ebi...
#neoEBM
@atulmalhotra.bsky.social
Reposted by Abdul Razak
NEW PAPER

Compromised cardiopulmonary transition in fetal growth restricted and small for gestational age neonates

Suboptimal fetal growth → altered cardiac structure/function → higher risk of impaired adaptation at birth, respiratory morbidity, and long-term CV risk.

doi.org/10.1113/JP28...
Compromised cardiopulmonary transition in fetal growth restricted and small for gestational age neonates
Abstract figure legend Differences in cardiovascular function between appropriately grown (AG) and fetal growth restricted (FGR) infants after the cardiopulmonary transition at birth. AG infants typi....
doi.org
September 16, 2025 at 12:50 AM
Reposted by Abdul Razak
New publication from our group covering aspects of the talk I will be giving at Neonatal Update in London later this year.

Cord blood-derived cell therapy for preterm brain injury
www.sciencedirect.com/science/arti...

@drabdulrazak.bsky.social @courtney-mcdonald.bsky.social
Cord blood-derived cell therapy for preterm brain injury
Preterm birth, defined as delivery before 37 weeks of gestation, remains a leading contributor to neonatal morbidity and long-term neurodevelopmental …
www.sciencedirect.com
August 22, 2025 at 1:36 PM
Reposted by Abdul Razak
Early Neurodevelopment of Extremely Preterm Infants Administered Autologous Cord Blood Cell Therapy

Secondary Analysis of CORD-SaFe study now out in @jamanetworkopen.com

jamanetwork.com/journals/jam...

@drabdulrazak.bsky.social @courtney-mcdonald.bsky.social @hudsonresearch.bsky.social
July 4, 2025 at 2:57 AM
Glad to share our 2 Cochrane network meta-analyses investigating use of 7 diff. non-invasive respiratory support in preterm infants

Post-extubation www.cochranelibrary.com/web/cochrane...

Primary www.cochranelibrary.com/web/cochrane...
@ebneo.bsky.social @monashuniversity.bsky.social
Postextubation use of non‐invasive respiratory support in preterm infants: a network meta‐analysis - Razak, A - 2025 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
www.cochranelibrary.com
July 2, 2025 at 10:34 PM
Tiny warriors to the rescue! 💥

Matched stem cells from healthy newborns donated at birth now being trialed to help preterm babies with severe brain injury @monashuniversity.bsky.social

Protocol just out
@atulmalhotra.bsky.social @courtney-mcdonald.bsky.social
bmjopen.bmj.com/content/bmjo...
June 18, 2025 at 8:42 AM
More isn’t always better!

Adding systemic hydrocortisone to intrapulmonary budesonide in preterm ventilation didn’t boost lung outcomes—in fact, it blunted the benefits & triggered early brain inflammation

Commentary: rdcu.be/eraxD

Study: nature.com/articles/s4139…
@atulmalhotra.bsky.soci
al
June 16, 2025 at 11:54 AM
When we see parents doing kangaroo care, we should sincerely thank them as this simple act is saving lives!

New SRMA published in @lancetchildadol.bsky.social confirms this intervention as high quality evidence in reducing death
www.thelancet.com/journals/lan...
@ebneo.bsky.social
June 2, 2025 at 10:34 PM
New meta-analysis on PDA management suggesting harm associated with active treatment compared to expectant management
jamanetwork.com/journals/jam...
May 28, 2025 at 9:10 AM
Feeling incredibly proud to receive the @theracp.bsky.social
Fellowship Award in support of ongoing PhD work!

Grateful to be part of a brilliant research team driving this forward!
@atulmalhotra.bsky.social @courtney-mcdonald.bsky.social @monashuniversity.bsky.social
May 26, 2025 at 8:56 AM
Thrilled to share our latest article spotlighting the emerging power of umbilical cord blood cells in treating neonatal diseases!

A great read and a promising start for UCBC applications
@atulmalhotra.bsky.social
publications.aap.org/neoreviews/a...
May 1, 2025 at 4:42 AM
Reposted by Abdul Razak
Association Between Hammersmith Infant Neurological Examination and Bayley Scales of Infant Development in High-Risk Infants: A Retrospective Cohort Study onlinelibrary.wiley.com/doi/full/10....

@drabdulrazak.bsky.social
Association Between Hammersmith Infant Neurological Examination and Bayley Scales of Infant Development in High‐Risk Infants: A Retrospective Cohort Study
Click on the article title to read more.
onlinelibrary.wiley.com
March 7, 2025 at 10:11 AM
Lungs need pressure to grow!

RCT demonstrates extended CPAP promotes lung growth and gas exchange
#neoEBM @ebneo.bsky.social
atsjournals.org/doi/10.1164/rc…
February 22, 2025 at 12:13 AM
We could feed 30-33 week babies exclusively enterally from day 1 with no TPN or IV fluids which results in many gains including shorter hospital stay by almost 1 week as demonstrated in this RCT
@ebneo.bsky.social
t.co/5byENdNLlU
https://www.nature.com/articles/s41372-025-02217-0
t.co
February 3, 2025 at 1:48 PM
Reposted by Abdul Razak
Preprint (not peer-reviewed) of the next CORD-SaFe paper is out:

Early Neurodevelopmental Outcomes of Extremely Preterm Infants Administered Autologous Cord-Blood Derived Cell Therapy
papers.ssrn.com/sol3/papers....

Lindsay Zhou @drabdulrazak.bsky.social
January 23, 2025 at 11:27 PM
Reposted by Abdul Razak
Attending #PAS2025?

Don't miss our workshop on Evaluating Trustworthiness: Identifying Spin, Fraud, and Deception in Modern Research

Date: Friday, April 25, 2025
Time: 4:00 PM - 5:30 PM

@ebneo.bsky.social
Rasheda Vereen @atulmalhotra.bsky.social @briankingneo.bsky.social @drabdulrazak.bsky.social
January 21, 2025 at 9:57 AM
Reposted by Abdul Razak
Also - check out our workshop entitled "Evaluating trustworthiness: identifying spin, fraud and deception in modern research" on Friday at 4:00 pm with @drabdulrazak.bsky.social, Rasheda Vereen and Atul Malhotra @ebneo.bsky.social
January 17, 2025 at 7:10 PM
Glad to share the PhD project on persistent inflammation in a novel intrauterine ovine model is selected for oral presentation

It also gets Trainee Award🎊

See you all at Hawaii
@atulmalhotra.bsky.social @courtney-mcdonald.bsky.social @monashuniversity.bsky.social
January 17, 2025 at 7:44 PM
Reposted by Abdul Razak
Sharing new paper from our workshop in #PAS2023

Navigating Information Overload on Social Media: Opportunities & Misadventures for Clinicians and Professionals www.newbornjournal.org/abstractArti...

@briankingneo.bsky.social @souvikneo.bsky.social

#neosky @ebneo.bsky.social @espr-esn.bsky.social
December 21, 2024 at 11:38 PM
Reposted by Abdul Razak
Dr. Shrivastava and @drabdulrazak.bsky.social review a NMA on DR O2 in preterm infants.
Read: buff.ly/49RD1zM
Commentary: buff.ly/3P6AJmX
Discuss @99nicu.bsky.social: buff.ly/3Du0SJP
Incubator podcast: buff.ly/3PaXhmg
#neosky #EBNEOreviews
@jama.com
December 22, 2024 at 10:16 PM
Reposted by Abdul Razak
It's time for the 5th @ebneo.bsky.social Impact Article of the Year campaign! We'll close 2024 by reviewing #neoebm highlights from 2023. A year from dissemination, have these pubs impacted your neonatal care? #neosky

✅ Consider the 8 nominees by following the links: buff.ly/3R5JhMy

1/2
December 20, 2024 at 10:01 PM
Reposted by Abdul Razak
Zhou et al publish their phase I trial into autologous cord blood stem cells administration. buff.ly/3ZAP287 #neoEBM #neosky #EBNEOalerts @atulmalhotra.bsky.social @drabdulrazak.bsky.social
December 14, 2024 at 3:56 PM
Reposted by Abdul Razak
A decade of our preclinical work went into this world first clinical trial treating extremely preterm babies with their own cord blood stem cells. Very proud of the team for this one. Please check it out. @atulmalhotra.bsky.social @hudsonresearch.bsky.social

www.thelancet.com/journals/ebi...
Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (CORD-SaFe study)
This phase-1 clinical trial has shown UCBC collection and reinfusion was feasible in approximately 70% of extremely preterm infants and was well tolerated without any serious adverse events.
www.thelancet.com
December 18, 2024 at 10:03 AM
Thrilled to see one of the PhD chapters win the Best Publication Award of the Year!

This project is truly deserving, as it supports early detection of cerebral palsy in babies through a high-performing clinic at MCH led by @atulmalhotra.bsky.social
@hudsonresearch.bsky.social
December 18, 2024 at 7:24 AM